Literature DB >> 18428243

Methylation-specific PCR.

J G Herman1, S B Baylin.   

Abstract

Methylation-specific PCR is a rapid method used to determine the methylation status of DNA. Not only does methylation affect the expression of genes in normal cells, but it is now known that disease processes such as cancer can result in abnormal DNA methylation patterns. Methylation-specific PCR can be used to investigate imprinted genes, to assess human tumors for clonality by studying genes inactivated on the X chromosome, and to examine abnormally methylated CpG islands in neoplasia.

Entities:  

Mesh:

Year:  2001        PMID: 18428243     DOI: 10.1002/0471142905.hg1006s16

Source DB:  PubMed          Journal:  Curr Protoc Hum Genet        ISSN: 1934-8258


  5 in total

Review 1.  [Pyrosequencing in uro-oncology: applications in prostate cancer].

Authors:  T C Stadler; A Jung; B Schlenker; P Nuhn; J Ellinger; T Kirchner; C G Stief; P J Bastian
Journal:  Urologe A       Date:  2010-11       Impact factor: 0.639

2.  Hypermethylation reduces the expression of PNPLA7 in hepatocellular carcinoma.

Authors:  Xiaojiao Zhang; Jun Zhang; Rui Wang; Shicheng Guo; Huilu Zhang; Yanyun Ma; Qingmei Liu; Haiyan Chu; Xianghong Xu; Yitong Zhang; Dongqin Yang; Jiucun Wang; Jie Liu
Journal:  Oncol Lett       Date:  2016-06-01       Impact factor: 2.967

Review 3.  Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities.

Authors:  Goran Micevic; Nicholas Theodosakis; Marcus Bosenberg
Journal:  Clin Epigenetics       Date:  2017-04-04       Impact factor: 6.551

4.  Epigenetic, genetic and environmental interactions in esophageal squamous cell carcinoma from northeast India.

Authors:  Fazlur Rahman Talukdar; Sankar Kumar Ghosh; Ruhina Shirin Laskar; Rosy Mondal
Journal:  PLoS One       Date:  2013-04-15       Impact factor: 3.240

5.  Novel multiplex MethyLight protocol for detection of DNA methylation in patient tissues and bodily fluids.

Authors:  Ekaterina Olkhov-Mitsel; Darko Zdravic; Ken Kron; Theodorus van der Kwast; Neil Fleshner; Bharati Bapat
Journal:  Sci Rep       Date:  2014-03-21       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.